Innovations move refractive surgery along path back to the surface

Article

As the evolution in refractive surgery continues, surgeons can expect to see the journey continuing back to the surface—aided by new strategies to improve the outcomes of sub-Bowman's keratomileusis (SBK) and PRK.

As the evolution in refractive surgery continues, surgeons can expect to see the journey continuing back to the surface—aided by new strategies to improve the outcomes of sub-Bowman's keratomileusis (SBK) and PRK, said John Marshall, PhD, in his keynote address at Refractive Surgery Subspecialty Day.

SBK, involving creation of a very superficial flap using a femtosecond laser, was introduced to provide the benefits of both LASIK and PRK. Since creation of the very thin flap minimally reduces the strength of the cornea, SBK is expected to provide the biomechanical stability of PRK, but like LASIK, without the pain and haze that are sequelae of post-PRK wound healing, he said.

Looking to the future, Dr. Marshall suggested biomechanical stability after SBK can be further improved by changing the edge angle of the flap.

"Making the edge angle more oblique makes the flap stronger," said Dr. Marshall, head of the department of ophthalmology, Kings College, London.

Recognizing that wound healing is a limiting variable for PRK, Dr. Marshall suggested the surface ablation procedure will be improved by pharmacologic modulation of that process. Possible strategies include use of the simple sugar, mannose 6-phosphate, and aptamer technology.

"Studies from our group show that mannose 6-phosphate, which blocks receptor sites on keratocytes, is effective in preventing haze in animal models," Dr. Marshall said. "In addition, we have found that aptamers selectively differentiating between activated and latent keratocytes can be used for targeted wound healing control."

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.